Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Board/Management Information 2024

May 22, 2024

62616_rns_2024-05-22_dc3ad593-45b0-4f16-a8cd-26033374afe0.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [154 x 50] intentionally omitted <==

May 22, 2024

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Scrip Code: STAR

The BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001. Scrip Code: 532531

Dear Sirs,

Sub: Outcome of Board Meeting on May 22, 2024

We wish to inform you that as part of strengthening Strides’ Board and comprehensive succession planning by promoting internal talent, following appointments/ changes in Board composition and Management of the Company have been approved by the Board of Directors of the Company based on the recommendations of Nomination and Remuneration Committee. The said changes shall be effective from June 1, 2024.

  • 1) Appointment of Mr. Subir Chakraborty (DIN: 00130864) as Independent Director of the Company;

  • 2) Other Board & Management changes are as under:

# Name Current Designation/ Role New Role/ Designation
1 Mr. Arun Kumar
(DIN: 00084845)
Executive Chairperson &
Managing Director
Executive Chairperson
2 Mr. Badree Komandur
(DIN: 07803242)
Executive Director – Finance &
Group CFO
MD & Group CEO
3 Mr. Aditya Kumar
(DIN: 06999081)
VP – B2B Business Executive Director – Business
Development
4 Mr. Vikesh Kumar CFO – Front End Markets Group CFO &
Chief Investor Relations Officer
5 Ms. Surabhi Loshali Sr. VP – HR Group CHRO

Disclosure pursuant to Regulation 30 of SEBI Listing Regulations in relation to above is enclosed as an Annexure.

The Board Meeting commenced at 11:30 hrs IST and ended at 13:30 hrs IST.

==> picture [506 x 48] intentionally omitted <==

==> picture [154 x 50] intentionally omitted <==

This is for your kind information and record purposes.

Thanks & Regards, For Strides Pharma Science Limited, MANJULA Digitally signed by MANJULA R R Date: 2024.05.22 13:35:44 +05'30' Manjula Ramamurthy Company Secretary ICSI Membership No. A30515 Encl. as above

==> picture [90 x 88] intentionally omitted <==

==> picture [506 x 48] intentionally omitted <==

==> picture [154 x 50] intentionally omitted <==

Disclosure pursuant to Regulation 30 of SEBI Listing Regulation relating to Board & Management Changes

1) Mr. Subir Chakraborty as Independent Director of the Company effective June 1, 2024

# Details Information of such event
1. Reasons for change, viz.,
appointment~~, resignation, removal,~~
~~death or otherwise~~
Mr. Subir Chakraborty (DIN: 00130864) is appointed as
Additional Director of the Company under the category of
Non-Executive and Independent effective June 1, 2024 for a
period of five years, subject to Shareholders’ approval.
With over four decades of working experience in various
capacities, his expertise in operations and ESG, Subir’s
induction to the Board will be of immense benefit for the
Company.
2. Date of appointment/ re-
appointment/ cessation and
term of appointment/ re-appointment
3. Brief profile
(in case of appointment)
Subir Chakraborty aged 66 years has spent more than four
decades working in various capacities in several
organizations such as Berger Paints, Balmer Lawrie & Co
Ltd and Exide Industries Ltd, out of which he spent more
than two and half decades in the last-named company, rising
from the level of General Manager to the apex level, through
several tiers in the company. He joined the Exide board in
2013 serving in various capacities, prior to becoming the
Managing Director & CEO in 2021.
Subir qualified as a Mechanical Engineer from IIT Madras,
earning his B.Tech in 1980 with Distinction. Thereafter, he
worked for two years as an engineer, and then enrolled at IIM
Calcutta to pursue a Post Graduate Program in Management,
completing his PGDM in 1984.
Subir is deeply involved in business bodies and associations
and is the immediate past President of Bengal Chamber of
Commerce & Industry (BCCI). He has also been a National
Council Member of Confederation of Indian Industry (CII)
for the years 2022-24.
Subir has received several accolades and awards during his
career, including the India Energy Storage Alliance (IESA)
Lifetime Achievement Award in May 2023 as well as the
Distinguished Alumnus Award from Indian Institute of
Management, Calcutta in Nov 2023.
Subir remains interested in academic pursuits and has been a
guest faculty at several reputed management institutions of
repute, such as IIM Calcutta. He is committed to the cause of
sustainability and spearheaded multiple initiatives at Exide to
further this objective. He has also delivered several addresses
on this topic at important forums and is a sought-after
speaker on the subject. His speeches are all available in the
publicmedia.

==> picture [506 x 48] intentionally omitted <==

==> picture [154 x 50] intentionally omitted <==

Subir has operated for more than ten years at the board level
of Exide and several other subsidiaries both in India as well
as abroad. After traversing an eventful career path of around
forty-two years, he has retired from Exide effective May 1,
2024.
4. Disclosure of
relationships between
directors
(in case of appointment of a director)
None
5. Other information pursuant to BSE
Circular with ref. no. LIST/ COMP/
14/ 2018-19 and NSE Circular with
ref. no. NSE/ CML/ 2018/ 24.
Subir is not debarred from holding the office of Director
pursuant to any SEBI Order or any other statutory authority.

==> picture [506 x 48] intentionally omitted <==


==> picture [154 x 50] intentionally omitted <==

2) Mr. Arun Kumar as Executive Chairperson effective June 1, 2024

# Details Information of such event
1. Reasons for change, viz.,
~~appointment, resignation, removal,~~
~~death or~~otherwise
Re-designation of Mr. Arun Kumar (DIN: 00084845), as
‘Executive Chairperson’ of the Company effective June 1,
2024.
Arun is currently the Executive Chairperson & Managing
Director of the Company.
Consequent to the said re-designation, Arun shall cease to be
the Managing Director of the Company effective closing
business hours of May 31, 2024 and continue his role as
Executive Chairperson of the Company.
2. Date of appointment/ re-
appointment/ cessation and
term of appointment/ re-appointment
3. Brief profile
(in case of appointment)
Not Applicable
4. Disclosure of
relationships between
directors
(in case of appointment of a director)
5. Other information pursuant to BSE
Circular with ref. no. LIST/ COMP/
14/ 2018-19 and NSE Circular with
ref. no. NSE/ CML/ 2018/ 24, both
dated June 20, 2018.
Arun is not debarred from holding the office of Director
pursuant to any SEBI Order or any other statutory authority.

==> picture [506 x 48] intentionally omitted <==


==> picture [154 x 50] intentionally omitted <==

3) Mr. Badree Komandur as MD & CEO effective June 1, 2024

# Details Information of such event
1. Reasons for change, viz.,
~~appointment, resignation, removal,~~
~~death~~or otherwise
Appointment and re-designation of Mr. Badree Komandur
(DIN: 07803242) as ‘Managing Director & Group CEO’ of the
Company for a period of three years with effect from June 1,
2024, subject to Shareholders’ approval.
Badree is currently the Executive Director – Finance & Group
CFO of the Company.
Consequent to the above appointment, Badree shall cease to
be the Group CFO of the Company with effect from the
closing business hours of May 31, 2024.
2. Date of appointment/ re-
appointment/ cessation and
term of appointment/ re-appointment
3. Brief profile
(in case of appointment)
Mr. Badree Komandur, aged 52 years, holds a degree in
Commerce from the University of Madras and is a Member
of the Institute of Chartered Accountants of India, the
Institute of Company Secretaries of India and the Institute of
Cost Accountants of India.
Badree has over 28 years of rich and comprehensive
experience in Corporate Finance & Taxation, Treasury, Forex
Management, Mergers & Acquisitions, Debt Syndication &
Management, Fund Raising, Governance and Investor
Relations Management, amongst others.
Badree is associated with Strides since February 2010 and
before joining Strides, he had over 15 years of experience
working in varied sectors including Information Technology
and Engineering.
Prior to his appointment as Executive Director of the
Company in May 2017, Badree was the Group CFO and
Company Secretary of the Company. Badree is a key
management personnel and has played an influential role in
implementing Company’s strategies.
During his tenure at Strides, he has led the finance function
and provided stewardship in Corporate Finance & Taxation,
Treasury, Forex Management, Mergers & Acquisitions, Debt
Syndication & Management, Fund Raising, Governance, and
Investor Relations Management, amongst others.
He has also played an instrumental role in driving global
compliances, risk management and govern overall financial
discipline in the system.
He also oversees the Information Technology and Global
Centre of Excellence functions. Recently, Badree also took
up additional responsibilities of heading Human Resources &
Administration functions globally.
4. Disclosure of
relationships between
directors (in case of appointment of a
director)

==> picture [506 x 48] intentionally omitted <==

==> picture [154 x 50] intentionally omitted <==

  1. Other information pursuant to BSE Badree is not debarred from holding the office of Director Circular with ref. no. LIST/ COMP/ pursuant to any SEBI Order or any other statutory authority. 14/ 2018-19 and NSE Circular with ref. no. NSE/ CML/ 2018/ 24, both dated June 20, 2018.

==> picture [506 x 48] intentionally omitted <==

==> picture [154 x 50] intentionally omitted <==

4) Mr. Aditya Arun Kumar as Executive Director – Business Development effective June 1, 2024

# Details Information of such event
1. Reasons for change, viz.,
appointment~~, resignation, removal,~~
~~death or otherwise~~
Appointment of Mr. Aditya Arun Kumar (DIN: 06999081) as
whole-time director designated as ‘Executive Director –
Business Development’ of the Company for a period of three
years with effect from June 1, 2024, subject to Shareholders’
approval.
Aditya is currently heading the B2B Business of the Company.
Consequent to the said elevation, Aditya is also appointed as
one of the KMPs of the Company effective June 1, 2024.
Coordinate of Aditya is as under:
Email ID: [email protected]
Phone: +91 80 6784 0118
2. Date of appointment/ re-
appointment/ cessation and
term of appointment/ re-appointment
3. Brief profile
(in case of appointment)
Mr. Aditya Arun Kumar, aged 35 years, holds a Bachelors
Degree in Biomedical Sciences from Newcastle University
and a Master of Research in Biophysics from Kings College,
London.
Aditya started his career with Strides as a Management
Trainee and since then held multiple positions in Strides and
Family Office prior to his current role.
Aditya has over 10 years of experience in the pharma
industry predominantly in Business Development roles.
Before heading the B2B business for Strides, he was also
responsible for integrating two acquired consumer divisions.
From 2017-2022, Aditya led the business of a promoter-
funded pharmaceutical start-up that is the second such
technology platform that can develop and manufacture oral
lyophilisates.
Aditya has been leading the global partnered business at
Strides since June 2022. In this role, he has been instrumental
in adding new customers across geographies enabling growth
and sustainability. The business under his leadership has
grown in size and scale.
4. Disclosure of
relationships between
directors
(in case of appointment of a director)
Aditya is son of Mr. Arun Kumar, Founder and Executive
Chairperson of the Company.
Except the above, Aditya is not related to any other Directors
of the Company.

==> picture [506 x 48] intentionally omitted <==

==> picture [154 x 50] intentionally omitted <==

  1. Other information pursuant to BSE Aditya is not debarred from holding the office of Director Circular with ref. no. LIST/ COMP/ pursuant to any SEBI Order or any other statutory authority. 14/ 2018-19 and NSE Circular with ref. no. NSE/ CML/ 2018/ 24, both dated June 20, 2018.

==> picture [506 x 48] intentionally omitted <==

==> picture [154 x 50] intentionally omitted <==

5) Mr. Vikesh Kumar as Group CFO of the Company effective June 1, 2024

# Details Information of such event
1. Reasons for change, viz.,
appointment~~, resignation, removal,~~
~~death or otherwise~~
Appointment of Mr. Vikesh Kumar as Group CFO of the
Company effective June 1, 2024.
Consequently, he is also classified as KMP of the Company
effective June 1, 2024.
Vikesh is currently CFO of the Front-End Markets.
Further, Vikesh is also appointed as Chief Investor Relations
Officer of the Company effective June 1, 2024.
Coordinate of Vikesh is as under:
Email ID: [email protected]
Phone: +91 80 6784 0347
2. Date of appointment/ re-
appointment/ cessation and
term of appointment/ re-appointment
3. Brief profile
(in case of appointment)
Mr. Vikesh Kumar, aged 39 years, holds a Post Graduate
Diploma in Management (PGDM) from S.P Jain Institute of
Management & Research, Mumbai.
Vikesh has over 15 years of rich and comprehensive
experience in Business Finance, Mergers & Acquisitions,
Treasury, Forex Management, Fund Raising, Governance and
Investor Relations Management, amongst others.
Vikesh is associated with Strides since June 2009, joining as
part of the campus recruitments for the Strides Leadership
program of 2009.
During his tenure at Strides, he has built and led the business
finance function for the group, building it as the nerve centre
of the organization, partnering business and functional heads
in executing the company’s plans.
He also has played lead roles in Mergers & Acquisitions,
Governance, Fund Raising, Treasury, Forex Management and
Investor Relations Management, amongst others.
Prior to his appointment as CFO for the Front-End businesses
in May 2022, Vikesh was the Head of Business Finance for
the group. In his role as the CFO for the Front-End
businesses, he relocated to the US in August 2023, to drive
the reset strategy in the geography with focus on building
profitable, sustainable cash generating operations.
As part of the leadership team in the US, he led the revival of
Chestnut Ridge manufacturing operations and enabled the
company to set industry leading benchmarks in the Front-End
operations.

==> picture [506 x 48] intentionally omitted <==

==> picture [154 x 50] intentionally omitted <==

4. Disclosure of
relationships between directors
(in case of appointment of a director)
Not Applicable
5. Other information pursuant to BSE
Circular with ref. no. LIST/ COMP/
14/ 2018-19 and NSE Circular with
ref. no. NSE/ CML/ 2018/ 24.
Not Applicable
***

==> picture [506 x 48] intentionally omitted <==

==> picture [154 x 50] intentionally omitted <==

6) Ms. Surabhi Loshali as CHRO of the Company effective June 1, 2024

# Details Information of such event
1. Reasons for change, viz., appointment~~,~~
~~resignation, removal, death or~~
~~otherwise~~
Ms. Surabhi Loshali is appointed as the Chief Human
Resource Officer (CHRO) of the Company with effect from
June 1, 2024.
Surabhi is currently heading Talent Management for the
Group.
Consequent to the above, Surabhi is nominated as one of the
Senior Management Personnel of the Company.
2. Date of appointment/ re-appointment/
cessation and term of appointment/ re-
appointment
3. Brief profile
(in case of appointment)
Ms. Surabhi Loshali, aged 44 years, holds a degree in
Polymer Science & Chemical Engineering from Delhi
College of Engineering and MBA from XLRI Jamshedpur.
Surabhi has over 20 years of experience in human resources
and specializes in people strategy, organizational
transformation, talent management, organization design,
employee experience, people analytics, HR technology,
mergers & acquisitions and amongst others.
Surabhi has worked globally in countries across Americas,
Europe and Asia.
Surabhi is associated with Strides since September 2020.
Before joining Strides, she had over 17 years of experience
in supporting leaders across various industries including
manufacturing, life sciences, financial services and
information technology.
During her tenure at Strides, she has set up the talent
management function and liaised with Arcolab Center of
Excellence teams to institutionalize HR processes to
enhance employee experience.
As a part of her talent management role, she has initiated
structured talent assessment and development initiatives for
first time managers and future leaders. Her efforts with
respect to diversity initiatives have borne fruit and Strides
has been awarded as the Best Organization for Women
Empowerment for 2024 amongst the manufacturing
organizations.
4. Disclosure of relationships between
directors (in case of appointment of a
director)
Not Applicable

==> picture [506 x 48] intentionally omitted <==

==> picture [154 x 50] intentionally omitted <==

5. Other information pursuant to BSE
Circular with ref. no. LIST/ COMP/
14/ 2018-19 and NSE Circular with
ref. no. NSE/ CML/ 2018/ 24.
Not Applicable

==> picture [506 x 48] intentionally omitted <==